$ELF

e.l.f. Beauty (ELF) & Ulta Beauty (ULTA): Rhode Is Carrying e.l.f. Beauty. Ulta Is Winning on Rich Shoppers Instead

e.l.f. Beauty (ELF) reported Q1 sales of $479.4M, up 36%, driven by its acquired Rhode brand. Ulta Beauty (ULTA) saw Q1 sales rise 11% to $3.16B, boosted by prestige brands. ELF raised FY guidance, but its core brand declined. ULTA's growth was broad-based, with higher customer spending.

Original reporting
Published Aug 21, 2026, 9:30 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 21, 2026, 10:27 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
e.l.f. Beauty (ELF) & Ulta Beauty (ULTA): Rhode Is Carrying e.l.f. Beauty. Ulta Is Winning on Rich Shoppers Instead — source image
Decision brief

The 30-second read

$ELFBullishMed
01

Why it matters

Guidance upgrades and sales beats provide fresh data for traders; concentration risk and macro uncertainty remain key considerations.

02

Market read

Earnings beats and guidance lifts for two major beauty retailers offer actionable insights, with ELF showing brand concentration risk and ULTA showing broad-based affluent growth.

03

What to watch

Tariff refund boost is one‑time; macro uncertainty could pressure Ulta's lower‑income shoppers.

Relevance 7/10Novelty 7/10Timing: post‑quarter earnings release

Background

Both e.l.f. Beauty and Ulta Beauty released their latest quarterly results, with e.l.f. highlighting a $1B acquisition-driven surge and Ulta emphasizing affluent consumer growth.

Company-level read

Ticker impact

$ELFBullishMedium confidence
Context

e.l.f. Beauty posted Q1 sales of $479.4M, beat estimates, and raised full-year guidance to $1.94B-$1.97B with EPS $3.50-$3.55.

Expected impact

Potential upside on earnings beat and guidance, tempered by concentration concerns.

Evidence & confidence

Guidance lift is material, but one‑time tariff refund and brand concentration limit conviction.

$ULTABullishMedium confidence
Context

Ulta Beauty reported fiscal Q1 sales of $3.16B, up 11% YoY, beating estimates and showing broad‑based growth.

Expected impact

Likely modest upside as investors price in solid top‑line growth.

Evidence & confidence

Sales beat is fresh data; no major one‑time items, indicating sustainable momentum.

Market effects

Beauty sector may see increased focus on celebrity‑driven brands and affluent consumer spending.

U.S. consumer discretionary stocks could benefit from Ulta's affluent shopper trend.

Highlights the risk of brand concentration for global cosmetics companies.

Counterpoint

Investors may short ELF if Rhode brand momentum stalls, given core brand decline.

Key entities

  • Mandy Fields

    CFO of e.l.f. Beauty who discussed guidance raise.

  • Kecia Steelman

    CEO of Ulta Beauty who commented on growth and macro concerns.

Related articles

$ULTAHighAI 8/10

Ulta Beauty Stock Is Down Today. Now Could Be a Good Time to Buy.

Ulta Beauty (ULTA) shares fell after Q2 earnings. Sales rose 8.9% to $3B, EPS up 13.3% to $6.55, beating estimates. Management raised full-year guidance. Inventory and expenses well-managed, but traffic growth and promotions noted as concerns. Stock trades at 18x earnings, with a $1B buyback plan.

$ULTAMedAI 8/10

Ulta (ULTA) Stock Trades Down, Here Is Why

Ulta Beauty (ULTA) shares fell 3.5% despite Q2 earnings beat and raised full-year guidance due to slower projected H2 growth and higher ticket prices. Net sales rose 8.9% YoY to $3.04B, with EPS at $6.55. The stock trades at $519.50, down 4.4% from prior close. Ulta appointed Brieane Olson, CEO of Pacific Sunwear, to its board.

$ULTAMedAI 9/10

Ulta Beauty earnings analysis: questions answered and next catalysts

Ulta Beauty (ULTA) reported Q2 earnings exceeding estimates, with EPS at $6.55 and revenue at $3.00B, but shares fell 4% due to concerns about H2 growth. The company showed market share gains, SG&A leverage, and accelerated capital returns. Despite raising FY guidance, the market is cautious about margin recovery and H2 risks. Key catalysts include Q3 earnings, holiday season performance, and SG&A leverage proof.